Bayer CropScience and Plant Health Care sign Myconate development and commercialization agreement
Plant Health Care will receive an undisclosed up-front payment, two milestone payments, dependent on the progress of the development, over the next two years and supply payments. The companies believe that Myconate enhanced seed treatment products could be available to growers as early as 2009, subject to regulatory approvals.
In the seed treatment segment, Bayer CropScience offers a broad portfolio of high-quality products to combat pests and fungal diseases. Plant Health Care´s Myconate technology is known to help crops to develop larger root mass through the stimulation of naturally occurring mycorrhizal fungi, which in turn often leads to improved yields and enhanced stress resistance. Both companies will collaborate on the further development of Myconate as a seed treatment product in corn, soybean, cotton and sunflower on a worldwide basis.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.